Comparative effectiveness of 6x R-CHOP21 versus 6x R-CHOP21 + 2 R for patients with advanced-stage diffuse large B-cell lymphoma.
Saved in:
| Title: | Comparative effectiveness of 6x R-CHOP21 versus 6x R-CHOP21 + 2 R for patients with advanced-stage diffuse large B-cell lymphoma. |
|---|---|
| Authors: | Maas CCHM; Department of Public Health, Erasmus University Medical Centre, Rotterdam, The Netherlands. c.h.m.maas@erasmusmc.nl.; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands. c.h.m.maas@erasmusmc.nl., van Klaveren D; Department of Public Health, Erasmus University Medical Centre, Rotterdam, The Netherlands., Durmaz M; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands.; Amsterdam UMC, Department of Hematology, Cancer Center Amsterdam, Amsterdam, The Netherlands., Visser O; Department of Registration, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands., Issa DE; Department of Internal Medicine, Jeroen Bosch Hospital, Den Bosch, The Netherlands., Posthuma EFM; Department of Internal Medicine, Reinier de Graaf Gasthuis, Delft, The Netherlands.; Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands., Zijlstra JM; Amsterdam UMC, Department of Hematology, Cancer Center Amsterdam, Amsterdam, The Netherlands., Chamuleau MED; Amsterdam UMC, Department of Hematology, Cancer Center Amsterdam, Amsterdam, The Netherlands., Lugtenburg PJ; Erasmus MC Cancer Institute, University Medical Center Rotterdam, Department of Hematology, Rotterdam, The Netherlands., Kersten MJ; Amsterdam UMC, Department of Hematology, Cancer Center Amsterdam, Amsterdam, The Netherlands.; LYMMCARE (Lymphoma and Myeloma Center Amsterdam), Amsterdam, The Netherlands., Dinmohamed AG; Department of Public Health, Erasmus University Medical Centre, Rotterdam, The Netherlands. a.dinmohamed@iknl.nl.; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands. a.dinmohamed@iknl.nl.; Amsterdam UMC, Department of Hematology, Cancer Center Amsterdam, Amsterdam, The Netherlands. a.dinmohamed@iknl.nl.; LYMMCARE (Lymphoma and Myeloma Center Amsterdam), Amsterdam, The Netherlands. a.dinmohamed@iknl.nl. |
| Source: | Blood cancer journal [Blood Cancer J] 2024 Sep 12; Vol. 14 (1), pp. 157. Date of Electronic Publication: 2024 Sep 12. |
| Publication Type: | Journal Article; Comparative Study |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
